Impaired function of dendritic cells deficient in angiotensin II type 1 receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 3, 2010, Pages 854-862

  Nahmod, Karen ^a   Gentilini, Ciara ^b   Vermeulen, Monica ^a,c   Uharek, Lutz ^b   Wang, Yong ^d,e   Zhang, Jialin ^e   Schultheiss, Heinz Peter ^b   Geffner, Jorge ^a,c   Walther, Thomas ^d,e  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d UNIVERSITY OF HULL   (United Kingdom)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; B7 ANTIGEN; CD11 ANTIGEN; CD40 ANTIGEN; COLONY STIMULATING FACTOR 1; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CD4 LYMPHOCYTE COUNT; CELL CULTURE; CELL ISOLATION; DENDRITIC CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL SEPARATION; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; ENDOCYTOSIS; FLOW CYTOMETRY; GENE; GENETICS; GENOTYPE; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; T LYMPHOCYTE; ULTRASTRUCTURE; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD11C; BLOTTING, WESTERN; CELL SEPARATION; CYTOKINES; DENDRITIC CELLS; ENDOCYTOSIS; FLOW CYTOMETRY; GENES, MHC CLASS II; GENOTYPE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES; UP-REGULATION;

EID: 77956253228     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.161760     Document Type: Article

References (40)

1. Banchereau J and Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252.
2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, and Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811.
3. Brasier AR, Li J, and Wimbish KA (1996) Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 27:1009-1017.
4. Chan YC and Leung PS (2007) Angiotensin II type 1 receptor-dependent nuclear factor-κB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis. J Pharmacol Exp Ther 323:10-18.
5. Constantinescu CS, Goodman DB, and Ventura ES (1998) Captopril and lisinopril suppress production of interleukin-12 by human peripheral blood mononuclear cells. Immunol Lett 62:25-31.
6. de Gasparo M, Catt KJ, Inagami T, Wright JW, and Unger T (2000) International union of pharmacology XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472.
7. De Smedt T, Pajak B, Muraille E, Lespagnard L, Heinen E, De Baetselier P, Urbain J, Leo O, and Moser M (1996) Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 184:1413-1424.
8. Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, et al. (2005) Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352: 558-569.
9. Ernsberger P and Koletsky RJ (2007) Metabolic actions of angiotensin receptor antagonists: PPAR-γ agonist actions or a class effect? Curr Opin Pharmacol 7:140-145.
10. Fernandez-Castelo S, Arzt ES, Pesce A, Criscuolo ME, Diaz A, Finkielman S, and Nahmod VE (1987) Angiotensin II regulates interferon-γ production. J Interferon Res 7:261-268.
11. Fukuzawa M, Satoh J, Sagara M, Muto G, Muto Y, Nishimura S, Miyaguchi S, Qiang XL, Sakata Y, Nakazawa T, et al. (1997) Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo. Immunopharmacology 36:49-55.
12. Gembardt F, Heringer-Walther S, van Esch JH, Sterner-Kock A, van Veghel R, Le TH, Garrelds IM, Coffman TM, Danser AH, Schultheiss HP, et al. (2008) Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors. FASEB J 22:3068-3077.
13. Haznedaroǧlu IC and Büyükaşik Y (1997) Current evidence for the existence of a local renin-angiotensin system affecting physiologic and pathological haematopoiesis in the bone marrow. Br J Haematol 99:471.
14. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, and Murakami K (1999) Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103:627-635.
15. Hubert C, Savary K, Gasc JM, and Corvol P (2006) The hemaopoietic system: a new niche for the renin-angiotensin system. Nat Clin Pract Cardiovasc Med 3:80-85.
16. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, and Coffman TM (1995) Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 92:3521-3525.
17. Jurewicz M, McDermott DH, Sechler JM, Tinckam K, Takakura A, Carpenter CB, Milford E, and Abdi R (2007) Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol 18:1093-1102.
18. Lapteva N, Ide K, Nieda M, Ando Y, Hatta-Ohashi Y, Minami M, Dymshits G, Egawa K, Juji T, and Tokunaga K (2002) Activation and suppression of renin-angiotensin system in human dendritic cells. Biochem Biophys Res Commun 296:194-200.
19. Lapteva N, Nieda M, Ando Y, Ide K, Hatta-Ohashi Y, Dymshits G, Ishikawa Y, Juji T, and Tokunaga K (2001) Expression of renin-angiotensin system genes in immature and mature dendritic cells identified using human cDNA microarray. Biochem Biophys Res Commun 285:1059-1065. (Pubitemid 32918045)
20. Liu EC, Hedberg A, Goldenberg HJ, Harris DN, and Webb ML (1992) DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptors. Prostaglandins 44:89-99.
21. Lutz MB, Kukutsch N, Ogilvie AL, Rössner S, Koch F, Romani N, and Schuler G (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223:77-92.
22. Marshall TG, Lee RE, and Marshall FE (2006) Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b. Theor Biol Med Model 3:1.
23. McCartney-Francis N, Jin W, and Wahl SM (2004) Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-β1 signaling pathway. J Immunol 172:3814-3821.
24. Miyoshi M, Miyano K, Moriyama N, Taniguchi M, and Watanabe T (2008) Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor κB and activator protein-1 activation. Eur J Neurosci 27:343-351.
25. Miyoshi M, Nagata K, Imoto T, Goto O, Ishida A, and Watanabe T (2003) ANG II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats. Am J Physiol Regul Integr Comp Physiol 284:R1092-R1097.
26. Nahmod KA, Vermeulen ME, Raiden S, Salamone G, Gamberale R, Fernández- Calotti P, Alvarez A, Nahmod V, Giordano M, and Geffner JR (2003) Control of dendritic cell differentiation by angiotensin II. FASEB J 17:491-493.
27. Nataraj C, Oliverio MI, Mannon RB, Mannon PJ, Audoly LP, Amuchastegui CS, Ruiz P, Smithies O, and Coffman TM (1999) Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 104:1693-1701.
28. Nie W, Yan H, Li S, Zhang Y, Yu F, Zhu W, Fan F, and Zhu J (2009) Angiotensin- (1-7) enhances angiotensin II induced phosphorylation of ERK1/2 in mouse bone marrow-derived dendritic cells. Mol Immunol 46:355-361.
29. Oliverio MI, Kim HS, Ito M, Le T, Audoly L, Best CF, Hiller S, Kluckman K, Maeda N, Smithies O, et al. (1998) Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci USA 95:15496-15501.
30. Phillips MI and Kagiyama S (2002) Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs 3:569-577.
31. Raiden S, Giordano M, Andonegui G, Trevani AS, López DH, Nahmod V, and Geffner JR (1997) Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl- phenylalanine to neutrophil receptors. J Pharmacol Exp Ther 281:624-628.
32. Sadoshima J (2000) Cytokine actions of angiotensin II. Circ Res 86:1187-1189.
33. Sallusto F and Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J Exp Med 179:1109-1118.
34. Sánchez-Lemus E, Benicky J, Pavel J, Larrayoz IM, Zhou J, Baliova M, Nishioku T, and Saavedra JM (2009) Angiotensin II AT1 blockade reduces the lipopolysaccharide- induced innate immune response in rat spleen. Am J Physiol Regul Integr Comp Physiol 296:R1376-R1384.
35. Schupp M, Janke J, Clasen R, Unger T, and Kintscher U (2004) Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-γ activity. Circulation 109:2054-2057.
36. Shimizu H, Miyoshi M, Matsumoto K, Goto O, Imoto T, and Watanabe T (2004) The effect of central injection of angiotensin-converting enzyme inhibitor and the angiotensin type 1 receptor antagonist on the induction by lipopolysaccharide of fever and brain interleukin-1β response in rats. J Pharmacol Exp Ther 308:865-873.
37. Shortman K and Liu YJ (2002) Mouse and human dendritic cell subtypes. Nat Rev Immunol 2:151-161.
38. Strawn WB, Richmond RS, Ann Tallant E, Gallagher PE, and Ferrario CM (2004) Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol 126:120-126.
39. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, and Egido J (2003) Inflammation and angiotensin II. Int J Biochem Cell Biol 35:881-900.
40. Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, Zahner G, Helmchen U, and Stahl RA (1997) Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest 100:1047-1058.